In this study, we have demonstrated that PR-IRS2 axis can also be preferentially activated by MPA in CAFs derived from obese patients, and not in cells from non-obese patients, suggesting the role of PR-IRS2 signaling in the tumor microenvironment of obese patients. Here, IRS2 is linked to neoplasm.